BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2017
View Archived Issues
Skinvisible and Quoin Pharmaceuticals enter non-binding term sheet for proposed merger
Read More
HEALOS phase III study of AM-111 does not meet the primary efficacy endpoint
Read More
Positive topline data reported from Abide Therapeutics' phase Ib study of ABX-1431
Read More
Aptevo Therapeutics to conduct phase II study of otlertuzumab
Read More
Preclinical antidepressant effects seen with sestrin-2 modulator NV-5138
Read More
C-458 shows promising results for Alzheimer's disease treatment
Read More
G1 Therapeutics enters clinical trial collaboration with AstraZeneca
Read More
Viking Therapeutics phase II study of VK-5211 meets primary endpoint
Read More
PhaseBio Pharmaceuticals obtains license to ticagrelor reversal agent
Read More
Synpromics and UCL enter Parkinson's disease gene therapy collaboration
Read More
Gilead and X-Chem form drug discovery collaboration
Read More
Phase III JAVELIN Gastric 300 trial of avelumab does not meet primary endpoint
Read More
FDA grants priority review to mogamulizumab BLA for CTCL
Read More
Takeda Pharmaceutical commences phase I study of Zika vaccine candidate TAK-426
Read More
GSK seeks U.S. approval for tafenoquine for prevention of relapse of P. vivax malaria
Read More
Hepatera and MYR report interim results from phase IIb study of Myrcludex B
Read More
Charles River and Enyo collaborate to identify mode of action of EYP002 series
Read More
Phase I data support inclusion of adolescents in Ovid's phase II trial of OV-101
Read More
Researchers present new DT-induced PAH animal model
Read More
Phase I studies reveal signs of antiparkinsonian efficacy of PF-06649751
Read More
Abide Therapeutics describes novel monoglyceride lipase/monoacylglycerol lipase ABHD6 inhibitors
Read More
New anti-tenascin-C antibodies synthesized at Roche
Read More
A*STAR presents novel anti-CTLA-4 antibodies
Read More
Novel Staphylococcus epidermidis autoinducing peptide analogues discovered at WARF
Read More
TNB-383B, a novel bispecific antibody candidate with efficacy in multiple myeloma models
Read More